Related Experiment Video
Updated: Dec 21, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Electroclinical Findings of SYNJ1 Epileptic Encephalopathy
1Child Neurology Section, Department of Pediatrics, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, USA.
Insights
A novel genetic cause of early-onset epileptic encephalopathy was identified in a Saudi Arabian infant with severe epilepsy. This discovery highlights the role of SYNJ1 gene variants in progressive neurodegeneration and intractable seizures.
Area of Science:
- Neuroscience
- Genetics
- Pediatric Neurology
Background:
- Early-onset epileptic encephalopathies (EOEEs) are severe epilepsy syndromes causing progressive neurodegeneration.
- Identifying novel genetic causes is crucial for understanding EOEE etiology.
Observation:
- A Semitic (Saudi Arabian) infant presented with multifocal seizures, progressing to intractable infantile spasms and myoclonic seizures.
- Clinical and electroencephalographic findings were consistent with EOEE.
- Whole exome sequencing revealed a homozygous novel pathogenic variant (p.Q287PfsX27) in the SYNJ1 gene.
Findings:
- The identified SYNJ1 variant leads to a critical reduction in dual phosphatase activity.
- Clinical manifestations include early-onset intractable focal, myoclonic seizures, infantile spasms, hypotonia, and progressive neurodegeneration.
- Brain MRI is typically normal, while EEG shows diffuse slowing with epileptiform discharges or modified hypsarrhythmia.
Implications:
- This case describes a new form of EOEE linked to synaptic dysregulation.
- It underscores the importance of the SYNJ1 gene and synaptic pathways in severe epilepsy pathophysiology.
- Further research into SYNJ1 variants can improve diagnosis and therapeutic strategies for severe early-onset epilepsies.
Introduction:
Early-onset epileptic encephalopathies are among the most severe early-onset epilepsies, leading to progressive neurodegeneration. An increasing number of novel genetic causes continue to be uncovered as the primary etiology.
Results:
We report a girl infant of Semitic (Saudi Arabian) descent who presented with multifocal seizures and later developed intractable infantile spasms and myoclonic seizures. Her clinical features and electroencephalography were consistent with early-onset epileptic encephalopathy. Whole exome sequence analysis showed homozygous novel pathogenic variant (variant p.Q287PfsX27; coding DNA c.858_862delACAAA) in the SYNJ1 gene.
Conclusion:
This is a newly described early-onset epileptic encephalopathy secondary to a critical reduction of the dual phosphatase activity of SYNJ. Clinical features include early-onset intractable focal, myoclonic seizures, infantile spasms, and hypotonia progressing to spastic quadriparesis, opisthotonus, dystonia, profound developmental delay, and a progressive neurodegenerative course. Brain magnetic resonance imaging is usually normal. Electroencephalography shows diffuse slowing with multifocal epileptiform discharges or modified hypsarrhythmia. These findings further expand the clinical spectrum of synaptic dysregulation in patients with severe epilepsy and emphasize the importance of this biological pathway in seizure pathophysiology.
More Related Videos
11:54Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
Published on: January 29, 2018
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Electroconvulsive Therapy
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...